150 related articles for article (PubMed ID: 871029)
21. Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
McDonald JW; Stuart RK; Barnett HJ
Adv Exp Med Biol; 1977; 82():222-4. PubMed ID: 920363
[No Abstract] [Full Text] [Related]
22. A controlled study of the effect of sulfinpyrazone on platelet survival and on platelet-bound 14C-serotonin release in patients with previous myocardial infarction.
Cortellaro M; Boschetti C; Fassio G; Basagni M; Polli EE
Acta Haematol; 1979; 61(2):68-74. PubMed ID: 217218
[TBL] [Abstract][Full Text] [Related]
23. Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
Margulies EH; White AM; Sherry S
Drugs; 1980 Sep; 20(3):179-97. PubMed ID: 7000488
[TBL] [Abstract][Full Text] [Related]
24. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
Haas S; Ketterl R; Blümel G
Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
[TBL] [Abstract][Full Text] [Related]
25. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Hanson SR; Harker LA; Bjornsson TD
J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
[TBL] [Abstract][Full Text] [Related]
26. Platelet coagulant activities and serum lipids in transient cerebral ischemia.
Walsh PN; Pareti FI; Corbett JJ
N Engl J Med; 1976 Oct; 295(16):854-8. PubMed ID: 958287
[TBL] [Abstract][Full Text] [Related]
27. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
[TBL] [Abstract][Full Text] [Related]
28. Platelet survival time following aortic valve replacement.
Steele P; Weily H; Davies H; Ppppas G; Genton E
Circulation; 1975 Feb; 51(2):358-62. PubMed ID: 1112016
[TBL] [Abstract][Full Text] [Related]
29. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Ostendorf P
Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265
[No Abstract] [Full Text] [Related]
30. Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ishcemia.
Evans G
Surg Forum; 1972; 23(0):239-41. PubMed ID: 4601078
[No Abstract] [Full Text] [Related]
31. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Genton E; Gent M; Hirsh J; Harker LA
N Engl J Med; 1975 Dec; 293(23):1174-8. PubMed ID: 1102977
[No Abstract] [Full Text] [Related]
32. XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy.
Genton E; Barnett HJ; Fields WS; Gent M; Hoak JC
Stroke; 1977; 8(1):150-75. PubMed ID: 835152
[TBL] [Abstract][Full Text] [Related]
33. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
34. Interruption of tumor-associated platelet consumption with platelet enzyme inhibitors.
Slichter SJ; Weiden PL; O'Donnell MR; Storb R
Blood; 1982 Jun; 59(6):1252-8. PubMed ID: 6805531
[TBL] [Abstract][Full Text] [Related]
35. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease.
Dougherty JH; Levy DE; Weksler BB
Lancet; 1977 Apr; 1(8016):821-4. PubMed ID: 67334
[TBL] [Abstract][Full Text] [Related]
36. A randomized trial of aspirin and sulfinpyrazone in patients with TIA.
Candelise L; Landi G; Perrone P; Bracchi M; Brambilla G
Stroke; 1982; 13(2):175-9. PubMed ID: 7039004
[TBL] [Abstract][Full Text] [Related]
37. Treatment of impending stroke.
McDowell FH; Millikan CH; Goldstein M
Stroke; 1980; 11(1):1-3. PubMed ID: 7355423
[No Abstract] [Full Text] [Related]
38. [Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program].
Fontanilles F
Wien Med Wochenschr Suppl; 1980; 61():23-4. PubMed ID: 6930767
[No Abstract] [Full Text] [Related]
39. Use of platelet inhibitor drugs in peripheral and cerebral vascular disorders.
Breddin K
Bibl Haematol; 1977; 44():197-205. PubMed ID: 367358
[TBL] [Abstract][Full Text] [Related]
40. Platelet inhibitors in the treatment of thrombosis.
Hirsh J
Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
